Featured News

The Celiac Disease Foundation is matching donations, dollar for dollar, up to $25,000. Together we can protect those with celiac disease in crisis. 

For adults with celiac disease and non-celiac gluten sensitivity, the microbes in your gut do not influence how sensitive you are to gluten, a recent study found.

To share with you some insight into our advocacy work, I recently interviewed Mark Van de Water, Senior Advisor at Baker Donelson.

Researchers found that children initially diagnosed with potential celiac disease had a high risk of developing celiac disease.

A few highlights from research studies published in peer-reviewed journals in the last few months are products of the research grants CDF awarded.

The Celiac Disease Foundation announces its newest appointee, Casey Guber, to its Board of Directors.

DDW is hosting its first hybrid event. This year, you have the choice to attend in person in San Diego or virtually through their cutting-edge platform.

Anokion SA announced successful completion of its Phase 1 clinical trial evaluating KAN-101 for the treatment of celiac disease, with promising results.

A study from the University of Chicago has demonstrated that B-cells are required for the development of villous atrophy (intestinal damage) in celiac disease. This finding provides support for the exploration of B-cell–directed therapies for the treatment of celiac disease.

Celiac disease patients are at an increased risk, albeit small, of cancer, and the findings from these studies confirm the importance of a healthy immune system in cancer prevention. For patients with celiac disease, adhering to a strict, gluten-free diet is critical to maintaining a healthy immune system.